Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
IRE by stunning pulse therapy deviceThis is a prospective, open-label, single-arm, exploratory clinical trial conducted at our institution to investigate the use of Irreversible Electroporation (IRE) for the treatment of breast cancer. Cancer Non applicable À vérifier China À vérifier
IRE by stunning pulse therapy deviceThis is a prospective, open-label, single-arm, exploratory clinical trial conducted at our institution to investigate the use of Irreversible Electroporation (IRE) for the treatment of breast cancer. Cancer Non applicable À vérifier China À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
IRE by stunning pulse therapy device Cancer Non applicable NCT07263451 Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study RECRUITING

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.